Back

Periprocedural and postprocedural outcomes of patients with tricuspid aortic valve undergoing transcatheter aortic valve implantation with the myval valve

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Interventional treatment of aortic stenosis: procedure and outcome Aortic Valve Stenosis ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Nikolaos Ktenopoulos

Ippokrateio General Hospital of Athens, Athens (Greece)

3 More presentations in this session

Presentation thumbnail
Single-center prospective study of accurate neo 2 in valve-in-valve TAVI: procedural and mid-to-long term outcomes
Doctor G. Papadopoulos (Thessaloniki, GR)
Abstract Slides Video
Presentation thumbnail
Early clinical and hemodynamic comparison of the latest-generation Evolut FX and SAPIEN 3 Ultra RESILIA Valves in transcatheter aortic valve implantation
Doctor N. Takahashi (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Accurate Neo prosthetic valve for percutaneous treatment of pure aortic regurgitation
Mr L. Dominguez Rodriguez (Madrid, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Interventional treatment of aortic stenosis: procedure and outcome

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Effectiveness and safety of myval versus self-expanding valves in patients undergoing transcatheter aortic valve implantation:a systematic review and meta-analysis
thumbnail
Congress Presentation
Global prevalence and outcomes of transcatheter aortic valve replacement and surgical aortic valve replacement: a systematic review and meta-analysis
thumbnail
Congress Session
The 50 shades of TAVI

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources